Exhibit 5.1

RICHARDSON & PATEL LLP

10900 Wilshire Boulevard

Suite 500

Los Angeles, California 90024

Telephone (310) 208-1183

Facsimile (310) 208-1154

August 21, 2008

SKYSTAR BIO-PHARMACEUTICAL COMPANY

Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South,

Gaoxin District, Xi’an, Shaanxi Province, P.R. China

	Re:	SKYSTAR BIO-PHARMACEUTICAL COMPANY
		Registration Statement on Form S-1

Ladies and Gentlemen:

We have acted as counsel for Skystar Bio-pharmaceutical Company, a Nevada corporation (the “Company”), in connection with the registration with the Securities and Exchange Commission on Form S-1 of 3,136,368 units of the Company’s securities in an offering, including 272,728 units underlying an unit purchase option granted by the Company to the underwriter representative in the primary offering. Each unit is comprised of one share of the Company’s common stock, $0.001 par value per share (the "Shares") and one Class C warrant (the “Warrants”) to purchase ¼ share of common stock. In connection with this registration, we have reviewed the proceedings of the Board of Directors of the Company relating to the registration and the issuance (or the proposed issuance) of the Units, Warrants and Shares, the Articles of Incorporation and all amendments thereto of the Company, the Bylaws of the Company and all amendments thereto, and such other documents and matters as we have deemed necessary to render the following opinion.

Based upon that review, it is our opinion that the Units, Warrants and Shares now issued, as well as the Shares that may be issued upon exercise of the Warrants in accordance with their respective terms, will be legally issued, fully paid, and nonassessable. It is our further opinion that the Warrants and the unit purchase option issued to the underwriter representative in the offering, are each legal, binding obligations of the Company, fully paid and non-assessable.

We do not find it necessary for the purposes of this opinion to cover, and accordingly we express no opinion as to, the application of the securities or blue sky laws of the various states as to the issuance and sale of the Units, Shares or Warrants.

We consent to the use of this opinion in the registration statement filed with the Securities and Exchange Commission in connection with the registration of the Units, Shares or Warrants and to the reference to our firm under the heading "Legal Matters" in the registration statement.

Very truly yours,

RICHARDSON & PATEL LLP

/s/ Richardson & Patel LLP